September 17, 2008 (Munich, Germany) — A new study has found that early enzyme-replacement therapy brings the most benefit in patients with Fabry's disease. Dr Frank Weidemann (University Hospital ...
L-Asparaginase is an enzyme that has revolutionized the treatment of certain types of cancer, particularly acute lymphoblastic leukemia (ALL). This enzyme catalyzes the hydrolysis of asparagine, an ...
A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.
October 18, 2010 (Toronto, Ontario) — Enzyme replacement therapy using bone-targeted tissue-nonspecific alkaline phosphatase (TNSALP) is a promising treatment for children with hypophosphatasia, ...
ST. LOUIS — Nu-Calgon has launched PowerZyme™, a new liquid enzyme-based drain line treatment for use in the HVAC and food service markets. PowerZyme keeps drain lines flowing freely and addresses ...